Charles River

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Charles River and other ETFs, options, and stocks.

About CRL

Charles River Laboratories International, Inc. engages in providing products and services to help pharmaceutical and biotechnology companies. It operates through the following segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions. 

CEO
James C. Foster
CEOJames C. Foster
Employees
19,700
Employees19,700
Headquarters
Wilmington, Massachusetts
HeadquartersWilmington, Massachusetts
Founded
1947
Founded1947
Employees
19,700
Employees19,700

CRL Key Statistics

Market cap
8.32B
Market cap8.32B
Price-Earnings ratio
-57.14
Price-Earnings ratio-57.14
Dividend yield
Dividend yield
Average volume
1.69M
Average volume1.69M
High today
$171.93
High today$171.93
Low today
$161.46
Low today$161.46
Open price
$162.70
Open price$162.70
Volume
1.55M
Volume1.55M
52 Week high
$228.88
52 Week high$228.88
52 Week low
$91.86
52 Week low$91.86

Stock Snapshot

With a market cap of 8.32B, Charles River(CRL) trades at $168.92. The stock has a price-to-earnings ratio of -57.14.

During the trading session on 2026-02-21, Charles River(CRL) shares reached a daily high of $171.93 and a low of $161.46. At a current price of $168.92, the stock is +4.6% higher than the low and still -1.8% under the high.

Trading volume for Charles River(CRL) stock has reached 1.55M, versus its average volume of 1.69M.

The stock's 52-week range extends from a low of $91.86 to a high of $228.88.

The stock's 52-week range extends from a low of $91.86 to a high of $228.88.

CRL News

TipRanks 1d
Charles River price target lowered to $235 from $251 at TD Cowen

TD Cowen analyst Charles Rhyee lowered the firm’s price target on Charles River (CRL) to $235 from $251 and keeps a Buy rating on the shares. The firm said whil...

TipRanks 2d
Buy Rating on Charles River Labs: Attractive Entry Point as AI Fears Overhang Fundamentals and Multiple Expansion Potential

Analyst Charles Rhyee from TD Cowen maintained a Buy rating on Charles River Labs and decreased the price target to $235.00 from $251.00. Charles Rhyee has giv...

TipRanks 3d
Strategic Review at Charles River Laboratories Raises Deal Uncertainty, Execution Risks, and Shareholder Value Concerns

Charles River Laboratories Intl (CRL) has disclosed a new risk, in the Corporate Activity and Growth category. The analyst notes that Charles River Laboratorie...

Analyst ratings

56%

of 18 ratings
Buy
55.6%
Hold
38.9%
Sell
5.6%

More CRL News

TipRanks 3d
Charles River Labs Appoints Glenn Coleman as New CFO

An announcement from Charles River Labs ( (CRL) ) is now available. On February 18, 2026, Charles River Laboratories announced the appointment of Glenn Coleman...

Simply Wall St 3d
New Charles River Leaders May Shape Valuation, Debt And Governance Outlook

Charles River Laboratories International (NYSE:CRL) has appointed Glenn G. Coleman as Chief Financial Officer. The company has also named Kerry Dailey as Chief...

New Charles River Leaders May Shape Valuation, Debt And Governance Outlook
Nasdaq 3d
Charles River Earnings Call Transcript

AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX AD...

Charles River Earnings Call Transcript
Nasdaq 4d
Charles River's Matthew Daniel To Step Down; Appoints Glenn Coleman CFO, Kerry Dailey CLO

(RTTNews) - Charles River Laboratories International, Inc. (CRL), on Wednesday announced that Corporate Senior Vice President, General Counsel, Corporate Secret...

Charles River's Matthew Daniel To Step Down; Appoints Glenn Coleman CFO, Kerry Dailey CLO
TipRanks 4d
Charles River names Glenn Coleman CFO, Kerry Dailey chief legal officer

Charles River (CRL) announced two executive appointments. Glenn Coleman has been named the company’s next CFO and Kerry Dailey has been named to the newly-creat...

TipRanks 4d
Charles River appoints Glenn Coleman as CFO, Kerry Dailey as CLO

Charles River Laboratories (CRL) announced two executive appointments: Glenn G. Coleman has been named the company’s next CFO and Kerry Dailey has been named to...

Nasdaq 4d
Charles River Lab Loss Widens In Q4; Guides FY26

(RTTNews) - Charles River Laboratories International, Inc. (CRL), on Wednesday reported a wider fourth-quarter net loss compared with the previous year. The com...

Charles River Lab Loss Widens In Q4; Guides FY26

People also own

Based on the portfolios of people who own CRL. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.